Scott Kuhns

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment

Targeting the tumour vasculature: from vessel destruction to promotion

Analytical and functional similarity of Amgen biosimilar ABP 215 to bevacizumab

Prevalent Class I-Restricted T-Cell Response to the Theiler’s Virus Epitope D^b:VP2_121–130in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28